ELITA PALLASIGUI: Open Payments
NPI 1013376136 · N LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 2 | $242 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $146 |
| Napo Pharmaceuticals Inc | 1 | $131 |
| Gilead Sciences, Inc. | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $129 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Janssen Pharmaceuticals, Inc | 1 | $95 |
Products named: CAPLYTA, Mytesi, Epclusa, INGREZZA, COBENFY, CABENUVA, ABILIFY MAINTENA, APRETUDE.
Industry payments across NV — which companies pay providers there.
